NO20022147L - Mimetiske peptider for epitope av apolipoprotein B-100, konkatamer og modifiserte peptider derav, og vaksinesammensetningsom omfatter det samme - Google Patents

Mimetiske peptider for epitope av apolipoprotein B-100, konkatamer og modifiserte peptider derav, og vaksinesammensetningsom omfatter det samme

Info

Publication number
NO20022147L
NO20022147L NO20022147A NO20022147A NO20022147L NO 20022147 L NO20022147 L NO 20022147L NO 20022147 A NO20022147 A NO 20022147A NO 20022147 A NO20022147 A NO 20022147A NO 20022147 L NO20022147 L NO 20022147L
Authority
NO
Norway
Prior art keywords
peptides
concatams
apolipoprotein
epitopes
same
Prior art date
Application number
NO20022147A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022147D0 (no
Inventor
Hyo-Joon Kim
Hae-Jung Joung
Original Assignee
Hyo-Joon Kim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR10-2001-0054005A external-priority patent/KR100472841B1/ko
Application filed by Hyo-Joon Kim filed Critical Hyo-Joon Kim
Publication of NO20022147D0 publication Critical patent/NO20022147D0/no
Publication of NO20022147L publication Critical patent/NO20022147L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775Apolipopeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO20022147A 2000-09-04 2002-05-03 Mimetiske peptider for epitope av apolipoprotein B-100, konkatamer og modifiserte peptider derav, og vaksinesammensetningsom omfatter det samme NO20022147L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20000052055 2000-09-04
PCT/KR2001/001492 WO2002020040A1 (en) 2000-09-04 2001-09-04 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
KR10-2001-0054005A KR100472841B1 (ko) 2000-09-04 2001-09-04 아포지단백질 비-100의 에피토프에 대한 모조 펩타이드,그들의 연쇄물 또는 변형체와 이들을 함유하는 백신 조성물

Publications (2)

Publication Number Publication Date
NO20022147D0 NO20022147D0 (no) 2002-05-03
NO20022147L true NO20022147L (no) 2002-05-03

Family

ID=26638363

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022147A NO20022147L (no) 2000-09-04 2002-05-03 Mimetiske peptider for epitope av apolipoprotein B-100, konkatamer og modifiserte peptider derav, og vaksinesammensetningsom omfatter det samme

Country Status (18)

Country Link
US (1) US6825318B2 (lt)
EP (1) EP1315517B1 (lt)
JP (1) JP2004508029A (lt)
CN (1) CN1231262C (lt)
AU (1) AU8628601A (lt)
BG (1) BG106655A (lt)
BR (1) BR0107175A (lt)
CA (1) CA2389739A1 (lt)
CZ (1) CZ20021571A3 (lt)
EE (1) EE200200238A (lt)
HU (1) HUP0203251A2 (lt)
IL (1) IL149379A0 (lt)
LT (1) LT4989B (lt)
MX (1) MXPA02004505A (lt)
NO (1) NO20022147L (lt)
RU (1) RU2313536C2 (lt)
SK (1) SK6312002A3 (lt)
WO (1) WO2002020040A1 (lt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL379196A1 (pl) * 2003-06-11 2006-07-24 Schering Aktiengesellschaft Nowe zmodyfikowane cząsteczki koryny posiadające substytut sekwencji aktywacji i ich zastosowanie
KR100639397B1 (ko) * 2004-03-18 2006-10-26 (주)에스제이바이오메드 항비만용 면역원성 하이브리드 폴리펩타이드 및 이를포함하는 항비만 백신 조성물
US20070054298A1 (en) * 2005-08-12 2007-03-08 Kent Kirshenbaum Methods for enzyme-mediated coupling of oligomers
WO2007075335A2 (en) * 2005-12-16 2007-07-05 The Regents Of The University Of California Modulation of in utero immune programming
US8961982B2 (en) * 2005-12-16 2015-02-24 The Regents Of The University Of California Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer
RU2418005C2 (ru) * 2006-09-25 2011-05-10 ЭсДжей БАЙОМЕД ИНК. Иммуногенные гибридные полипептиды против ожирения и композиция вакцин против ожирения, содержащая эти полипептиды
CN103520713B (zh) * 2013-10-16 2015-10-28 西北农林科技大学 一种ApoB100酵母重组疫苗及其制备方法和应用
EP3463416A1 (en) 2016-05-31 2019-04-10 CardioVax, LLC Methods for diagnosing and treating systemic lupus erythematosus
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3215310A1 (de) * 1982-04-23 1983-10-27 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
CA2283474A1 (en) * 1997-03-04 1998-09-11 Bio-Technology General Corp. Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
AU2801299A (en) * 1998-03-04 1999-09-20 Bio-Technology General Corporation Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
EP1267908B1 (en) * 2000-03-03 2004-05-06 GlaxoSmithKline Biologicals S.A. Vaccine for the treatment of atherosclerosis

Also Published As

Publication number Publication date
EP1315517B1 (en) 2010-10-20
CA2389739A1 (en) 2002-03-14
SK6312002A3 (en) 2002-09-10
JP2004508029A (ja) 2004-03-18
BR0107175A (pt) 2002-07-02
RU2003109439A (ru) 2004-07-20
LT4989B (lt) 2003-01-27
BG106655A (bg) 2004-08-31
CN1392798A (zh) 2003-01-22
US6825318B2 (en) 2004-11-30
US20030211997A1 (en) 2003-11-13
MXPA02004505A (es) 2004-09-10
CZ20021571A3 (cs) 2002-09-11
IL149379A0 (en) 2002-11-10
WO2002020040A1 (en) 2002-03-14
EP1315517A1 (en) 2003-06-04
LT2002051A (lt) 2002-09-25
NO20022147D0 (no) 2002-05-03
AU8628601A (en) 2002-03-22
HUP0203251A2 (hu) 2003-01-28
CN1231262C (zh) 2005-12-14
RU2313536C2 (ru) 2007-12-27
EE200200238A (et) 2003-06-16
EP1315517A4 (en) 2005-02-09

Similar Documents

Publication Publication Date Title
CY2019029I2 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
DK1228217T3 (da) Konserverede neisseria-antigener
DK1584685T3 (da) Tumorassocieret antigenderivater fra Mage-familien, anvendt til fremstilling af fusionsproteiner med T-hjælper epitoper og sammensætninger til vaccination
DE60116439D1 (de) Gassperrfilm
DK1390066T3 (da) Vaccinesammensætning
EE200300264A (et) ß-amüloidpeptiidi äratundvad humaniseeritud antikehad
NO20023850D0 (no) Kompositt piezoelektrisk transformator
NO983141L (no) Antigene peptider
AU5249501A (en) Synthetic peptides that bind to the hepatitis b virus core and e antigens
DK1265633T3 (da) Vaccineadjuvans
DE60101168D1 (de) PTC Verbundwerkstoff
NO20030239D0 (no) Modifisert virus
NO20022147D0 (no) Mimetiske peptider for epitope av apolipoprotein B-100, konkatamer og modifiserte peptider derav, og vaksinesammensetningsom omfatter det samme
DE60105696D1 (de) Eisenhaltige Proteinzusammensetzung
EP1346721A4 (en) W/o/w composite emulsion
DE60042816D1 (de) T-helferzellen-epitope
EP1032583A4 (en) ACTIVE IMMUNIZATION AGAINST ANTIGENS ASSOCIATED WITH ANGIOGENESIS
MXPA03002875A (es) Composicion de vacuna y metodo de estabilizacion.
EP1197556A4 (en) USEFUL POLYPEPTIDES
NO20015376D0 (no) Peptider fra TT-virus-sekvensen og monospesifikke antistoffer som binder til TT-viruset
EP1359932A4 (en) TIP39 POLYPEPTIDES
AU2002952524A0 (en) Epstein barr virus peptide epitopes
IS6809A (is) Samsettar ónæmisglæðisblöndur
GB0030309D0 (en) Antibodies,Peptides,Analogs and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application